Pfizer, BioNTech submit pediatric vaccine data to FDA


Pfizer and BioNTech have submitted COVID-19 vaccine trial data on children ages 5 to 11 to the FDA, and they say they will formally apply for emergency use authorization "in the coming weeks." FDA officials previously said the agency could grant EUA to a COVID-19 vaccine for younger children in a matter of weeks once vaccine data is submitted, but the decision depends on the timing of submission and quality of data.

Full story:

AIChE SmartBrief

Chemical engineering news

Designed specifically for chemical engineers, AIChE SmartBrief is a FREE weekly e-mail newsletter. It helps chemical engineers stay informed on the business and technology developments affecting our profession.